Coronavirus Vaccine Distribution: Moving to a Race Conscious Approach for a Racially Disparate Problem

Johnson, James H.; Bonds, Jeanne Milliken; Parnell, Allan M.; Bright, Cedric M.

doi:10.1007/s40615-021-01051-2

Cited by 19 publications

(16 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Countries are approaching to combat the outrageous form of the pandemic. However, they have to face different issues such as low efficacy of the vaccine, shortage of vaccine production facilities, the origin of more virulent SARS-CoV-2 variant, difficulty in the world vaccine management system, and inability to develop effective antiviral drugs (Johnson et al 2021). So, the day-by-day, COVID-19 is becoming ferocious with multiform infections.…”

Section: Introductionmentioning

confidence: 99%

Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk Reduction

Baral

Amin

Rashid

et al. 2021

Rev. Bras. Farmacogn.

View full text Add to dashboard Cite

Pooled evidence conveys the association between polyunsaturated fatty acids and infectious disease. SARS-CoV-2, an enveloped mRNA virus, was also reported to interact with polyunsaturated fatty acids. The present review explores the possible mode of action, immunology, and consequences of these polyunsaturated fatty acids during the viral infection. Polyunsaturated fatty acids control protein complex formation in lipid rafts associated with the function of two SARS-CoV-2 entry gateways: angiotensin-converting enzyme-2 and cellular protease transmembrane protease serine-2. Therefore, the viral entry can be mitigated by modulating polyunsaturated fatty acids contents in the body. α-Linolenic acid is the precursor of two clinically important eicosanoids eicosapentaenoic acid and docosahexaenoic acid, the members of ω-3 fats. Resolvins, protectins, and maresins derived from docosahexaenoic acid suppress inflammation and augment phagocytosis that lessens microbial loads. Prostaglandins of 3 series, leukotrienes of 5 series, and thromboxane A 3 from eicosapentaenoic acid exhibit anti-inflammatory, vasodilatory, and platelet anti-aggregatory effects that may also contribute to the control of pre-existing pulmonary and cardiac diseases. In contrast, ω-6 linoleic acid-derived arachidonic acid increases the prostaglandin G 2 , lipoxins A 4 and B 4 , and thromboxane A 2 . These cytokines are pro-inflammatory and enhance the immune response but aggravate the COVID-19 severity. Therefore, the rational intake of ω-3-enriched foods or supplements might lessen the complications in COVID-19 and might be a preventive measure.

show abstract

Section: Introductionmentioning

confidence: 99%

Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk Reduction

Baral

Amin

Rashid

et al. 2021

Rev. Bras. Farmacogn.

View full text Add to dashboard Cite

show abstract

“…We can achieve our goals only if we direct resources toward addressing the root causes of deaths of despair and racially disparate impacts of COVID-19 by prioritizing access to health care and affordable housing [32].…”

Section: Equity Tools To Navigate Demographic Disruptorsmentioning

confidence: 99%

Urgently Needed: Equity Tools to Navigate Demographic Gale-Force Wind Gusts

Johnson

Bonds

Parnell

2022

North Carolina Medical Journal

Self Cite

View full text Add to dashboard Cite

Gale-force demographic disruptors such as unequal population growth can potentially prevent our state from achieving the exemplary goals and targeted outcomes set forth in Healthy North Carolina 2030. These forces also present opportunities if carefuly addressed. Policy prescriptions and strategic investments required to ensure success are outlined here, following an overview of demographic drivers that create public health vulnerabilities.

show abstract

“…Furthermore, because of the lack of capacity to appropriately refrigerate and administer the vaccine, current COVID-19 vaccines may take even longer to reach remote parts of low-income countries. Finally, evidence of racial and socioeconomic inequalities in the distribution of COVID-19 vaccines and the effects of this have been revealed within various nations, where high-risk people in communities of low-income status, racial and ethnic minorities, and persons with disability are having less access to the vaccines (40)(41)(42)(43). It appears that the inverse equity law has been proved again in the context of the new COVID-19 vaccines, and hence, the world will need several years to control the pandemic (34) (Figure 2).…”

Section: Inverse Equity and The Inverse Care Lawmentioning

confidence: 99%

Global control of COVID-19: good vaccines may not suffice

Eslava‐Schmalbach

Rosero

Garzón‐Orjuela

2021

Revista Panamericana De Salud Pública

View full text Add to dashboard Cite

The COVID-19 pandemic has unveiled health and socioeconomic inequities around the globe. Effective epidemic control requires the achievement of herd immunity, where susceptible individuals are conferred indirect protection by being surrounded by immunized individuals. The proportion of people that need to be vaccinated to obtain herd immunity is determined through the herd immunity threshold. However, the number of susceptible individuals and the opportunities for contact between infectious and susceptible individuals influence the progress of an epidemic. Thus, in addition to vaccination, control of a pandemic may be difficult or impossible to achieve without other public health measures, including wearing face masks and social distancing. This article discusses the factors that may contribute to herd immunity and control of COVID-19 through the availability of effective vaccines and describes how vaccine effectiveness in the community may be lower than that expected. It also discusses how pandemic control in some countries and populations may face vaccine accessibility barriers if market forces strongly regulate the new technologies available, according to the inverse care law.

show abstract

Coronavirus Vaccine Distribution: Moving to a Race Conscious Approach for a Racially Disparate Problem

Cited by 19 publications

References 18 publications

Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk Reduction

Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk Reduction

Urgently Needed: Equity Tools to Navigate Demographic Gale-Force Wind Gusts

Global control of COVID-19: good vaccines may not suffice

Contact Info

Product

Resources

About